BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11521104)

  • 1. [Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?].
    Castera L; Roulot D; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 2001 May; 25(5):509-13. PubMed ID: 11521104
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-infections. Hepatitis C virus--some background information.
    TreatmentUpdate; 2008; 20(3):5-8. PubMed ID: 18661654
    [No Abstract]   [Full Text] [Related]  

  • 3. [HIV and hepatitis coinfection].
    Ingiliz P; Rockstroh JK
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S216-8. PubMed ID: 16435714
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?'.
    Matthews G; Dore G
    AIDS; 2003 Dec; 17(18):2675-6. PubMed ID: 14685063
    [No Abstract]   [Full Text] [Related]  

  • 5. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the HCV pipeline heading in the right direction?
    Aronsohn A; Muir AJ; Swan T; Jensen D
    Gastroenterology; 2013 Mar; 144(3):482-5. PubMed ID: 23352458
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?
    Soriano V; Martín-Carbonero L; García-Samaniego J
    AIDS; 2003 Mar; 17(5):751-3. PubMed ID: 12646800
    [No Abstract]   [Full Text] [Related]  

  • 8. Tri-infection: successful treatment of a patient infected with HIV and hepatitis B and C viruses--a case report.
    Johanson F
    AIDS Read; 2004 Jul; 14(7):389-94. PubMed ID: 15282868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of liver cirrhosis.
    Lancet; 2014 May; 383(9930):1694. PubMed ID: 24835601
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment for hepatitis C in patients infected with human immunodeficiency virus.
    Fernández I; Muñoz R; Solís-Herruzo JA
    Rev Esp Enferm Dig; 2003 Apr; 95(4):287-91, 282-6. PubMed ID: 12826005
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hepatitis C virus/HIV coinfection.
    Chun S; Sherman KE
    Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Should Hepatitis C be treated? Objectives of antiviral treatments in hepatitis C virus infection].
    Degos F
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S57-65. PubMed ID: 9161515
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hepatitis C: advances and consensus].
    Lerebours E; Marcellin P; Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B5-6. PubMed ID: 12180308
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of chronic hepatitis B: recommendations from an Italian workshop.
    Carosi G; Rizzetto M
    Dig Liver Dis; 2008 Aug; 40(8):603-17. PubMed ID: 18499540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the standard of care: randomized controlled trials for the treatment of hepatitis C in the HIV-infected person.
    Sulkowski MS
    Hepatology; 2004 Apr; 39(4):906-8. PubMed ID: 15057892
    [No Abstract]   [Full Text] [Related]  

  • 17. New Indications for Harvoni.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):6. PubMed ID: 27099890
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C and B viruses: the new opportunists in HIV infection.
    Chung RT
    Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
    Brady CW; Muir AJ
    Hepatology; 2005 Aug; 42(2):496-7; author reply 497. PubMed ID: 16025502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.